Natural Product Research
1179
3.4. Acid hydrolysis of compound 1
A solution of compound 1 (10.0 mg) in 1N HCl (2 mL) was stirred at 100ꢃC under reflux in
a reaction flask for 4 h. Reaction mixture was transferred to separating funnel, diluted to
10 mL with water and extracted with water saturated EtOAc (3 ꢂ 5 mL). Both layers were
separately evaporated to dryness in vacuo. The EtOAc residue was subjected to gel
filtration on Sephadex LH-20 and eluted with MeOH. The aglycone of 1 was obtained as
pale yellow powder and was identified as 2,30,50,6-tetrahydroxy-4-methoxybenzophenone
on the basis of the melting point, co-TLC with an authentic sample, UV, IR and
ESIMS (Kitanov & Nedialkov, 2001). The sugar was identified as L-rhamnose by means of
co-TLC with an authentic sample on cellulose (Merck), mobile phase EtOAc-pyridine-
H2O (12 : 5 : 4) and spots were visualised with anisidine phtalate reagent (heating to 110ꢃC
for 3–5 min).
3.5. Molecular modelling
The optimisation of molecular geometry of 1 was done by ab initio calculation mode, using
GAMESS-US (Schmidt et al., 1993), Version 24 March 2007 R6, on a 32 bit Linux 2.6
box. The parameters were set to as follows: self-consistent field wavefunction was set to
Restricted Hatree Fock (RHF), the initial molecular geometry was given as Gaussian style
internals, Gaussian basis was set to Pople’s STO-NG minimal basis set, the number of
Gaussians was set to 3, C1 was chosen as a symmetry group, all other parameters were set
to defaults. The Molden program package Version 4.6 (Schaftenaar & Noordik, 2000) was
used for drawing initial geometry coordinates as well as for visualising calculation results
and for measuring intra molecular distances.
3.5.1. Elegaphenonoside (1)
25
White needles: m.p. 221–223ꢃC; ½ꢀꢀD ꢁ25.8 (c ¼ 2.01, MeOH); IR (nujol) ꢂmax: 3356.0,
2924.4, 2953.4, 2855.0, 1620.4, 1462.2, 1583.7; UV (MeOH) ꢃmax: 300 (4.25); (þAlCl3):
336, 371sh; (þNaOAc): 285, 371sh; 1H-NMR (300 MHz, CD3OD): 6.62 (2H, d, J ¼ 2.3 Hz,
H-20 and H-60), 6.46 (1H, t, J ¼ 2.3 Hz, H-40), 6.38 (1H, d, J ¼ 2.2 Hz, H-3), 6.19 (1H, d,
J ¼ 2.2 Hz, H-5), 5.26 (1H, d, J ¼ 1.8 Hz, H-100), 3.81 (3H, s, CH3O-4), 3.40–3.49 (2H, m,
H-200 and H-500), 3.28–3.35 (1H, m, H-400), 3.17 (1H, dd, J ¼ 3.4, 9.4 Hz, H-300), 1.20 (3H, d,
J ¼ 6.1 Hz, C-6); 13C-NMR (75 MHz, CD3OD): 198.8 (C¼O), 165.4 (C-4), 161.1 (C-6),
159.5 (C-30 and C-50), 158.5 (C-6), 143.3 (C-10), 110.3 (C-1), 108.2 (C-20 and C-60), 107.9
(C-40), 100.5 (C-100), 96.1 (C-5), 94.6 (C-3), 73.6 (C-400)þ, 72.0 (C-300), 71.þ5 (C-200), 70.9 (þC-500),
56.0 (CH3O-4), 18.0 (C-600); ESIMS: m/z 461 [M þ K] , 445 [M þ Na] , 423 [M þ H] , 405
[M ꢁ H2O þ H]þ, 277 [Magl]þ; FTMS: Calculated for [C20H22O10 þ H]þ 423.1286, found
423.1287; calculated for [C20H22O10 þ Na]þ 445.1105, found 445.1105; calculated for
[(C20H22O10)2 þ Na]þ 867.2318, found 867.2317.
Acknowledgement
This work was supported by Grant 31/2007 from the Medical Science Council at the Medical
University of Sofia.